Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23096)

• Formulation Name: Cabazitaxel 60mg/1.5ml solution
• Company: Sanofi Aventis Us

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Cabazitaxel	(DMPAZHC)	Breast cancer	2C60-2C65	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Citric acid monohydrate	(E00271)	22230	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent